It is important to have the right treatment for osteoporosis when the diagnosis is made.
To treat osteoporosis, there are 3 main categories of drugs:
- Against bone destruction.
They slow down or block the activity of cells responsible for bone destruction (osteoclasts) and reduce the risk of fractures, vertebrae and hips for bisphosphonates.
Bisphosphonates are the standard treatments for osteoprosis. However, their benefits are now widely discussed.
SERMs (estrogen receptor analogs), such as raloxifene, are especially indicated for women after menopause. They reduce the risk of fracture of vertebrae. This treatment also decreases the risk of developing breast cancer.
- For bone formation.
This drug stimulates the cells of bone formation (osteoblasts). This expensive drug is reimbursed only to women who have had two vertebral fractures, and its prescription is limited in time (18 months).
- The two-in-one
Strontium ranelate is both anabolic and anti-resorptive. It would increase bone formation while decreasing its destruction. However, this drug is currently less and less used, because of these side effects, especially cardiovascular. Its beneficial effects are also considered insufficient by the High Authority of Health.
- A new medicine